Diabetes and femoral neck strength: findings from the Hip Strength Across the Menopausal Transition Study
- PMID: 22072739
- PMCID: PMC3251942
- DOI: 10.1210/jc.2011-1883
Diabetes and femoral neck strength: findings from the Hip Strength Across the Menopausal Transition Study
Abstract
Context: Diabetes mellitus is associated with increased hip fracture risk, despite being associated with higher bone mineral density in the femoral neck.
Objective: The objective of the study was to test the hypothesis that composite indices of femoral neck strength, which integrate dual-energy x-ray absorptiometry derived femoral neck size, femoral neck areal bone mineral density, and body size and are inversely associated with hip fracture risk, would be lower in diabetics than in nondiabetics and be inversely related to insulin resistance, the primary pathology in type 2 diabetes.
Design: This was a cross-sectional analysis.
Setting and participants: The study consisted of a multisite, multiethnic, community-dwelling sample of 1887 women in pre- or early perimenopause.
Outcome measurements: Composite indices for femoral neck strength in different failure modes (axial compression, bending, and impact) were measured.
Results: Adjusted for age, race/ethnicity, menopausal stage, body mass index, smoking, physical activity, calcium and vitamin D supplementation, and study site, diabetic women had higher femoral neck areal bone mineral density [+0.25 sd, 95% confidence interval (CI) (+0.06, +0.44) sd] but lower composite strength indices [-0.20 sd, 95% CI (-0.38, -0.03) sd for compression, -0.19 sd, 95% CI (-0.38, -0.003) sd for bending, -0.19 sd, 95% CI (-0.37, -0.02) sd for impact] than nondiabetic women. There were graded inverse relationships between homeostasis model-assessed insulin resistance and all three strength indices, adjusted for the same covariates.
Conclusions: Despite having higher bone density, diabetic women have lower indices of femoral neck strength relative to load, consistent with their documented higher fracture risk. Insulin resistance appears to play an important role in bone strength reduction in diabetes.
Figures
Similar articles
-
Physical activity as determinant of femoral neck strength relative to load in adult women: findings from the hip strength across the menopause transition study.Osteoporos Int. 2014 Jan;25(1):265-72. doi: 10.1007/s00198-013-2429-z. Epub 2013 Jun 28. Osteoporos Int. 2014. PMID: 23812598 Free PMC article.
-
Trajectories of femoral neck strength in relation to the final menstrual period in a multi-ethnic cohort.Osteoporos Int. 2013 Sep;24(9):2471-81. doi: 10.1007/s00198-013-2293-x. Epub 2013 Feb 22. Osteoporos Int. 2013. PMID: 23436075 Free PMC article.
-
C-reactive protein, bone strength, and nine-year fracture risk: data from the Study of Women's Health Across the Nation (SWAN).J Bone Miner Res. 2013 Jul;28(7):1688-98. doi: 10.1002/jbmr.1915. J Bone Miner Res. 2013. PMID: 23456822 Free PMC article. Clinical Trial.
-
Hip fracture risk assessment using composite indices of femoral neck strength: the Rancho Bernardo study.Osteoporos Int. 2004 Jan;15(1):62-70. doi: 10.1007/s00198-003-1513-1. Epub 2003 Nov 7. Osteoporos Int. 2004. PMID: 14605798
-
Modelling Human Locomotion to Inform Exercise Prescription for Osteoporosis.Curr Osteoporos Rep. 2020 Jun;18(3):301-311. doi: 10.1007/s11914-020-00592-5. Curr Osteoporos Rep. 2020. PMID: 32335858 Free PMC article. Review.
Cited by
-
Use of noninvasive imaging to identify causes of skeletal fragility in adults with diabetes: a review.JBMR Plus. 2024 Jan 19;8(2):ziae003. doi: 10.1093/jbmrpl/ziae003. eCollection 2024 Feb. JBMR Plus. 2024. PMID: 38505529 Free PMC article. Review.
-
The nonlinear association between triglyceride glucose-body mass index and femoral neck BMD in nondiabetic elderly men: NHANES 2005-March 2020.PLoS One. 2024 Jan 23;19(1):e0296935. doi: 10.1371/journal.pone.0296935. eCollection 2024. PLoS One. 2024. PMID: 38261591 Free PMC article.
-
Associations of Type 2 Diabetes, Body Composition, and Insulin Resistance with Bone Parameters: The Dubbo Osteoporosis Epidemiology Study.JBMR Plus. 2023 Jun 8;7(9):e10780. doi: 10.1002/jbm4.10780. eCollection 2023 Sep. JBMR Plus. 2023. PMID: 37701154 Free PMC article.
-
Type 2 diabetes mellitus plays a protective role against osteoporosis --mendelian randomization analysis.BMC Musculoskelet Disord. 2023 Jun 2;24(1):444. doi: 10.1186/s12891-023-06528-1. BMC Musculoskelet Disord. 2023. PMID: 37268885 Free PMC article.
-
Prediabetes and Fracture Risk Among Midlife Women in the Study of Women's Health Across the Nation.JAMA Netw Open. 2023 May 1;6(5):e2314835. doi: 10.1001/jamanetworkopen.2023.14835. JAMA Netw Open. 2023. PMID: 37219902 Free PMC article.
References
-
- Janghorbani M, Van Dam RM, Willett WC, Hu FB. 2007. Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture. Am J Epidemiol 166:495–505 - PubMed
-
- Vestergaard P. 2007. Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes—a meta-analysis. Osteoporos Int 18:427–444 - PubMed
-
- Becker DJ, Kilgore ML, Morrisey MA. 2010. The societal burden of osteoporosis. Curr Rheumatol Rep 12:186–191 - PubMed
Publication types
MeSH terms
Grants and funding
- AG012553/AG/NIA NIH HHS/United States
- AG012539/AG/NIA NIH HHS/United States
- AG026463/AG/NIA NIH HHS/United States
- U01 AG012495/AG/NIA NIH HHS/United States
- U01 AG012505/AG/NIA NIH HHS/United States
- AG012535/AG/NIA NIH HHS/United States
- AG012546/AG/NIA NIH HHS/United States
- NR004061/NR/NINR NIH HHS/United States
- U01 AG012554/AG/NIA NIH HHS/United States
- R01 AG026463/AG/NIA NIH HHS/United States
- AG012554/AG/NIA NIH HHS/United States
- AG012531/AG/NIA NIH HHS/United States
- P30 AG028748/AG/NIA NIH HHS/United States
- U01 AG012535/AG/NIA NIH HHS/United States
- U01 AG012553/AG/NIA NIH HHS/United States
- AG033067/AG/NIA NIH HHS/United States
- U01 NR004061/NR/NINR NIH HHS/United States
- U01 AG012539/AG/NIA NIH HHS/United States
- AG012495/AG/NIA NIH HHS/United States
- U01 AG012546/AG/NIA NIH HHS/United States
- R01 AG033067/AG/NIA NIH HHS/United States
- U01 AG012531/AG/NIA NIH HHS/United States
- AG028748/AG/NIA NIH HHS/United States
- AG012505/AG/NIA NIH HHS/United States
